Simvastatin could be an effective therapy for portal hypertension, according to a study by Abraldes and colleagues, which shows that the drug decreases portal hypertension and improves liver ...
The liver cirrhosis treatment market is poised for significant growth, driven by the rising global prevalence of liver diseases, particularly NAFLD, fueled by lifestyle factors like obesity, alcohol ...
Causes of cirrhosis include metabolic dysfunction-associated steatotic liver disease (MASLD ... such as beta-blockers or nitrates (for portal hypertension). They may also recommend antibiotics ...
Intercurrent events were defined as any liver-related complication ... as an important therapy for patients with MASH cirrhosis and portal hypertension, a population with an unmet medical need ...
The global study, originally designed as a Phase 2b/3 trial, enrolled those with MASH (formerly known as NASH) cirrhosis who have clinical signs of portal hypertension and are at risk of ...
Megan took up rowing when she had to stop playing contact sports Liver disease such as cirrhosis, can also result in portal hypertension and cause an enlarged spleen. For Megan this meant she had ...
Liver transplantation has a beneficial effect on cognitive function in patients with cirrhosis, according to the results of a recent study investigating the long-term effects of liver ...